Delaware’s drug testing laws leave most private employers with wide discretion: there is no general state statute setting procedures for when or how employees and applicants can be tested. The real protections come from narrower sources. Delaware’s Medical Marijuana Act shields registered cardholders from adverse action based on a positive marijuana test alone. Federal law protects employees using legally prescribed medications and limits post-accident testing used as retaliation. Public works contractors, certain state agencies, and DOT-regulated transportation workers operate under mandatory testing programs that override the general at-will default.
What Private Employers Can Do
Delaware does not have a comprehensive private-sector drug testing statute. A private employer can generally require pre-employment screening, random testing, post-accident testing, or reasonable-suspicion testing without following specific state-mandated procedures for notice, consent, or confirmatory testing. Because Delaware is an at-will employment state, an employer can typically terminate an employee for a positive result unless another law prohibits it.
Broad discretion is not unlimited discretion. Federal law still applies. The Americans with Disabilities Act constrains how employers handle positive tests connected to prescribed medications. OSHA restricts post-accident testing used to punish injury reporting. And Delaware’s Medical Marijuana Act creates a cardholder protection that catches employers off guard because it goes further than most state laws in this area.
Employers who skip basic procedural safeguards like confirmatory testing and chain-of-custody documentation can still face wrongful termination or discrimination claims. Delaware courts recognize public policy exceptions to at-will termination, and the doctrine has limits when employer conduct crosses into discrimination or retaliation.
Medical Marijuana Cardholder Protections
Delaware’s Medical Marijuana Act, found in Title 16 Chapter 49A of the Delaware Code, prohibits employers from discriminating against a person in hiring, firing, or any condition of employment based on the person’s status as a registered cardholder, or based on a registered qualifying patient’s positive drug test for marijuana metabolites. The one situation where an employer can act on such a test is if the patient used, possessed, or was impaired by marijuana at the workplace or during work hours.
The statute also defines what impairment is not. A registered qualifying patient cannot be considered under the influence of marijuana solely because metabolites or components of marijuana appear in their system. This matters because THC metabolites can remain detectable for weeks after any impairment has worn off. A positive test on its own, without evidence of on-the-job use or actual impairment, is not grounds for adverse action against a cardholder.
There is a carve-out. If failing to act on the positive test would cause the employer to lose a monetary or licensing-related benefit under federal law or regulations, the employer may still take action. This mostly affects federal contractors and employers in federally regulated industries where marijuana remains prohibited.
Nothing in the Act forces an employer to allow on-site marijuana use or tolerate impairment at work. Employers can still prohibit consumption on their premises and discipline any employee who is actually impaired during working hours.
Recreational Marijuana Does Not Change the Rules
Delaware legalized recreational marijuana for adults 21 and older, but the legalization law does not alter employment law or require employers to accommodate cannabis use. If you are not a registered medical cardholder, you have no special statutory protection against being tested for marijuana or fired for a positive result. A private employer can maintain a zero-tolerance policy and enforce it through testing, including for off-duty use. The legislature chose to protect patients with qualifying conditions and left recreational users subject to employer discretion.
Public Works Contractor Testing Requirements
Workers on publicly funded construction projects in Delaware operate under a mandatory testing program that looks nothing like the private-sector default. Under 29 Del.C. § 6908(a)(6), every public works contract funded in whole or in part with public money must include a drug testing program for employees in nonclerical positions on the job site. The administrative regulations at 19 Del. Admin. Code § 4104 set out the specifics.
- At least 5% of a contractor’s employees must be randomly selected for drug testing each month, and at least 2.5% for alcohol testing.
- Reasonable-suspicion testing is allowed whenever a contractor, subcontractor, or project owner reasonably believes an employee is impaired, or when drug paraphernalia or open alcohol containers are found on the job site.
- Post-accident testing is required after any job-site accident involving property damage, injury, or death. The employee must report to a testing facility within four hours.
- Refusing to report or failing to cooperate with testing is treated as a positive result.
Contractors with fewer than 10 employees who don’t participate in a testing consortium must still test at least one randomly selected employee per month. These requirements apply to everyone working on qualifying public works projects.
State Agency and Sector-Specific Testing
Several Delaware statutes authorize or mandate testing in specific categories of employment. The Department of Services for Children, Youth and Their Families can test any employee or prospective employee in a safety, security-sensitive, or child care position for marijuana, cocaine, opiates, PCP, amphetamines, and other controlled substances specified by regulation. Consequences for a positive test or a refusal range from referral to the state’s Employee Assistance Program up to suspension or termination.
The Justice of the Peace Court must drug test any employee or applicant accepting a uniformed services position, including positions requiring an employer-issued firearm. Uniformed employees are also subject to random and reasonable-suspicion testing.
Home care agencies must obtain the results of a mandatory pre-employment drug screening before hiring an applicant under Title 16 § 1146 of the Delaware Code. Employers who fail to comply face civil penalties of $1,000 to $5,000 per violation.
Federal Protections That Apply in Delaware
Legally Prescribed Medications and the ADA
The Americans with Disabilities Act protects employees who test positive for a drug they were legally prescribed. Employers cannot automatically fire or refuse to hire someone because a drug test detected a prescribed opioid or other controlled medication. EEOC guidance is direct: if the use is legal and the employee is not disqualified by a separate federal law, the employer must consider whether there is a way for the person to do the job safely and effectively before disqualifying them. The same principle applies to employees in Medication Assisted Treatment programs for opioid use disorder.
Employers can ask employees who test positive to provide an explanation, such as a valid prescription. Any prescription information disclosed during testing must be kept confidential in separate medical files, not the general personnel record.
OSHA and Post-Accident Testing
OSHA does not ban post-accident drug testing, but it prohibits using testing to retaliate against employees who report work-related injuries. Requiring a test solely because an employee reported an injury, without a legitimate business reason, can draw an OSHA citation.
Permissible post-accident testing includes testing to evaluate the root cause of an incident that harmed or could have harmed employees, provided the employer tests everyone whose conduct could have contributed rather than only the person who reported the injury. Random testing, testing under workers’ compensation laws, and testing required by other federal rules like DOT regulations remain permissible. The dividing line is purpose: understanding the cause of an accident is legitimate; punishing an injury report is not.
DOT Rules for Transportation Workers
Federal Department of Transportation regulations create a separate framework that overrides state law for safety-sensitive transportation workers. This covers pilots, truck drivers, school bus drivers, train engineers, subway operators, ship captains, aircraft maintenance personnel, and pipeline emergency response personnel. If you hold one of these positions in Delaware, DOT rules govern.
DOT regulations require employers to immediately remove any safety-sensitive employee who has a verified positive drug test, an adulterated or substituted result, or an alcohol test at or above 0.04. The employee cannot return to safety-sensitive duties until completing a formal return-to-duty process.
Marijuana remains completely prohibited for DOT-regulated employees regardless of Delaware’s medical or recreational laws. The agency has also cautioned safety-sensitive workers about CBD products, noting that some contain more THC than their labels indicate.
Commercial driver’s license holders face an additional layer through the FMCSA Drug and Alcohol Clearinghouse. Employers must query the Clearinghouse before hiring any CDL driver and run annual queries for current CDL drivers. Violations reported to the Clearinghouse follow the driver across employers, making it effectively impossible to move to a new company without completing the return-to-duty process.
Challenging a Positive Result
What you can do about a result you believe is wrong depends on whether the test falls under federal rules or a private employer’s own policy.
For DOT-regulated tests, an employee has 72 hours from notification of a verified positive result to request testing of the split specimen. The request can be verbal or written. The Medical Review Officer will then direct the original laboratory to send the split to a second federally certified lab. If you miss the 72-hour window, the MRO may still grant the request if you can show that serious injury, illness, lack of actual notice, or inability to contact the MRO prevented a timely request.
The MRO also gives employees a chance to provide a legitimate medical explanation, such as a valid prescription, before any positive result is reported to the employer. That verification step exists specifically to prevent people from being flagged for lawfully prescribed medications.
For tests conducted by a private Delaware employer outside the DOT framework, state law does not mandate a specific appeals process, split-specimen procedure, or MRO review. This is where the absence of a comprehensive state statute works against employees. Two options remain. A registered medical marijuana cardholder can challenge adverse action under the anti-discrimination provisions of the Medical Marijuana Act. Any employee whose positive test came from a legally prescribed medication can potentially bring an ADA claim if the employer failed to engage in the required interactive process before taking action.